ALK and lung cancer: Asian patients with adenocarcinoma have higher prevalence of unique biologic features such as a higher incidence of oncogene-driven NSCLC (mainly EGFR-mutant and ALK-rearranged tumors), and the majority of Asian women with lung cancer are never-smokers.